Merck
2 known investors
Find your way into Merck
Sign up to see every warm intro you have to Merck
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Merck team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Merck is a science-led pharmaceutical company that develops medicines and vaccines for patients globally. The company focuses on innovation and long-term value creation through its research pipeline and commitment to healthcare advancement.
Founders & leadership
Investors · 2
Acquisitions · 1
Early investors' stakes continue via these dealsPandion Therapeutics
Developing biologic therapies for autoimmune disorders; acquired by Merck for $1.85B in 2021.
In the news
Frequently asked questions
- What does Merck do?
- Merck is a science-led pharmaceutical company that develops medicines and vaccines for patients globally. The company focuses on innovation and long-term value creation through its research pipeline and commitment to healthcare advancement.
- Who are Merck's investors?
- Merck's investors include MESA VERDE VENTURE PARTNERS, Sanderling Ventures.
